2002
DOI: 10.1016/s0011-393x(02)80103-5
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacotherapy for pediatric sleep disturbances: Current patterns of use and target populations for controlled clinical trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
9
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 48 publications
0
9
0
Order By: Relevance
“…Medication results from 80% of doctor visits for sleep (Stojanovski et al 2007 ). Medication presents a number of limitations, such as poor parental acceptance, long term inefficacy (France et al 1991 ), day time hangover effects (Wiggs and France 2000 ) and poor empirical support (Rosen et al 2002 ). Additionally, medication per se does not facilitate access to the environmental contingencies surrounding sleep and as such does not lead to learning of appropriate sleep onset behaviours.…”
Section: Introductionmentioning
confidence: 99%
“…Medication results from 80% of doctor visits for sleep (Stojanovski et al 2007 ). Medication presents a number of limitations, such as poor parental acceptance, long term inefficacy (France et al 1991 ), day time hangover effects (Wiggs and France 2000 ) and poor empirical support (Rosen et al 2002 ). Additionally, medication per se does not facilitate access to the environmental contingencies surrounding sleep and as such does not lead to learning of appropriate sleep onset behaviours.…”
Section: Introductionmentioning
confidence: 99%
“…[2][3][4][5] Even higher prevalence rates have been reported in special needs populations, such as children with neurologic impairments, mental retardation, and pervasive developmental disorder and autism, 6 and in children with a variety of psychiatric (eg, attentiondeficit/hyperactivity disorder [ADHD], depression) 7 and medical conditions (eg, juvenile rheumatoid arthritis, asthma). 8 A growing body of evidence shows that childhood sleep disturbances may have a wideranging impact on children's health; behavior; mood; neurobehavioral parameters such as attention, cognition, and memory; and school performance, as well as on parental stress and family life. 9 -14 A number of empirically sound and effective behavioral and cognitive/behavioral approaches to the treatment of pediatric insomnia, defined as significant and persistent difficulty in initiating and/or maintaining sleep, have been developed.…”
mentioning
confidence: 99%
“…A review of current patterns of use of pharmacotherapy for pediatric sleep disturbances (Rosen, Owens, Scher, & Glaze, 2002) highlights the issues in prescribing sleep medications. The authors report a lack of data to support either the efficacy or the tolerability of these medications for pediatric populations.…”
Section: Pharmacological Treatment Of Pediatric Sleep Disturbancesmentioning
confidence: 99%